Buying a second-hand car at a good price feels good. But choosing a delicious-looking doughnut in the supermarket leaves us riddled with doubt. After all, we resolved to eat a healthier diet this year—so wouldn't it be ...
Jan 12, 2022
0
61
A blood test, combined with a risk model based on an individual's history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published ...
Jan 7, 2022
0
86
Researchers are one step closer to developing a blood test that provides a simple biochemical hallmark for depression and reveals the efficacy of drug therapy in individual patients.
Jan 3, 2022
0
162
Fast and accurate clinical assessment of the disease progression and mortality is vital for the management of COVID-19 patients. Although several predictors have been proposed, they have been limited to subjective assessment, ...
Aug 30, 2021
0
545
Researchers at Tel Aviv University have found that exposure to ultraviolet radiation from sunlight enhances romantic passion in humans. In the study both men and women were exposed to UVB (ultraviolet radiation type B) under ...
Aug 25, 2021
0
439
In the fight against viruses, antibodies have the potential to either block infection or enable infection and make the disease worse, leading to concern about their use as a therapy for COVID-19.
Jun 21, 2021
0
27
Patients who, perhaps unbeknownst to their health care providers, are in need of genetic testing for rare undiagnosed diseases can be identified en masse based on routine information in electronic health records (EHRs), a ...
Jun 3, 2021
0
11
A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.
May 25, 2021
3
172
Researchers at the University of Alberta are preparing to launch clinical trials of a drug used to cure a deadly disease caused by a coronavirus in cats that they expect will also be effective as a treatment for humans against ...
Aug 27, 2020
3
2828
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.
Aug 4, 2020
0
21
